Biotech companies in India are known for their exceptional quality of highly-educated human resource. Most of them earned degrees in Western countries, especially in the field of process chemistry.
  Having a large English speaking population had allowed the Western pharmaceutical companies to enter into India from the very early stage. Since India was originally the key player in IT technology, the infrastructure of the industry has already been built in place years ago. Generic medicine industry is also growing and is expected to expand to the level to compete in the global market in near future.
  Rising costs of R&D and depletion of seeds have became burden on pharmaceutical companies. However, utilizing India’s experienced human resource and their technology in drug development with competitive costs have potential to solve these problems. Collaboration with India could be cost-effective for an efficient R&D in the future.

  Few Japanese companies have established collaboration with Indian companies in Life Science area, and MediBIC has been successfully working with Indian companies for the last several years. We can provide drug development solutions to our clients in collaboration with our partnerships in Asia.

ReaMetrix Inc. (India / America)
R&D and Marketing for diagnosis and reagent development

Strand Life Sciences
R&D Alliance on drug development support software using artificial intelligence program

Ali R. Zareh
Advisor, MediBIC Group
MediBIC Group Headquarter Office
New Nishi-Shinbashi Bldg, 5F,
2-11-6 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003 Japan
TEL +(81)-(0)3-6744-2882
FAX +(81)-(0)3-6744-2662